37 Market Reports Found
Search results:- European Markets for Skin Replacements/Substitutes and Active Wound Repair Modulators
Over the past two decades, dramatic advances have been made in the management of wound patients. These factors have gre ...[more]
- U.S Markets for Musculoskeletal Tissue Engineering and Cell Transplantation Products
This new report from Medtech Insight analyzes the market potential for tissue engineering products for musculoskeletal i ...[more]
- U.S. Markets for Cardiac and Vascular Tissue Engineering Products
Due to the large number of potential patients targeted by tissue engineering and cell transplantation technologies/produ ...[more]
- Emerging Medical Technologies Report
This 1,300+ page report includes detailed 2-3 page executive summaries on 577 emerging medical technology companies who ...[more]
- Worldwide Markets and Emerging Technologies for Tissue Engineering and Regenerative Medicine
The tissue engineering and regenerative medicine market first emerged in the mid-1990's with the introduction of product ...[more]
- U.S. Markets for Current and Emerging Wound Closure Technologies
In 2008, more than 100 million wounds were treated in U.S. hospitals; these included surgical wounds; traumatic wounds; ...[more]
- U.S. Surgical Procedure Volumes
The number of surgical procedures performed in the United States (U.S.) is increasing; however, the share of inpatient h ...[more]
- Opportunities in Global Medical Devices and Diagnostics
The global medical device and diagnostics (MD&D) industry generated nearly $286 billion in revenues in 2007, with contin ...[more]
- Current and Emerging U.S. Markets for Myocardial Revascularization, Repair, and Regeneration Products and Technologies
Heart disease is the leading cause of death in the U.S., killing one person nearly every minute. Coronary heart disease- ...[more]
- European Markets for Heart Valve Repair and Replacement Products
As the sizable European population both grows and ages, the number of people in the region living with congenital or acq ...[more]
- U.S. Surgical Procedure Volumes
The number of surgical procedures performed in the United States (U.S.) is increasing; however, the share of inpatient h ...[more]
- Tissue Engineering and Cell Transplantation: Technologies, Opportunities, and Evolving Markets in the U.S.
Due to the large number of potential patients targeted by tissue engineering and organ regeneration products, and the ma ...[more]
- U.S. Markets for Orthopedic Implant, Reconstruction, and Trauma Products
In 2006, U.S. sales of orthopedic implant, reconstruction, and trauma products totaled approximately $12.2 billion. Over ...[more]
- The U.S. Market for Spinal Fusion Orthobiologics, Bone Growth Stimulation, Disc Nucleus Altering Devices, and Vertebroplasty/Kyphoplasty Products
In 2006, more than $1.8 billion was spent on orthobiologics for spinal fusion, as well as bone growth stimulation, intra ...[more]
- Current and Emerging Technologies for the Management of Heart Failure in the U.S.
More than 5 million people in the U.S. are now being managed for heart failure, with 550,000 new cases occurring annuall ...[more]
- European Markets for Skin Replacements/Substitutes and Active Wound Repair Modulators
In 2005, the European skin replacements/ substitutes and active wound repair modulators market totaled approximately $25 ...[more]
- European Markets for New and Emerging Wound Closure Products and Techniques
In 2006, the European new and emerging wound closure products market (including ligating clips, mechanical stapling devi ...[more]
- Opportunities in Global Medical Devices and Diagnostics
The global medical device and diagnostics (MD&D) industry generated nearly $220 billion in revenues in 2005, of which ne ...[more]
- European Surgical Procedure Volumes
In previous years, conventional, open surgical procedures in the European Union (EU) countries of France, Germany, Ital ...[more]
- European Markets for Current and Emerging Orthopedic Biomaterials
...[more]
- European Markets for Current and Emerging Biomaterial-Based Arthroscopy Products
The European biomaterials-based arthroscopy products market, valued at approximately $550.3 million in 2005, offers cons ...[more]
- European Markets for Spinal Motion-Preserving Devices
An estimated 30 million people in the largest European Union (EU) countries of France, Germany, Italy, Spain and the Uni ...[more]
- European Markets for Spinal Fusion Products
Spinal fusion is a surgical procedure that stabilizes the vertebrae to alleviate debilitating pain caused by a degenerat ...[more]
- European Markets for Wound Dressings and Wound Cleansing/Debridement Products
Over the past 20 years, dramatic advances have been made in the management of wound patients. These factors have greatly ...[more]
- Opportunities in Men's Healthcare: U.S. Markets for Therapeutic Urology Products
Urology is a medical/surgical specialty involving the diagnosis and treatment of acute and chronic disorders of the urin ...[more]
- European Markets for Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting Products
Coronary artery disease is the leading cause of death in Europe. The morbidity/mortality rates associated with the dise ...[more]
- U.S. Markets for Tissue-Engineered Skin Replacements/Substitutes and Active Wound Repair Modulators
Designed for use in burn and wound patients to either temporarily cover or permanently replace areas of missing skin, sk ...[more]
- U.S. Markets for Wound Dressings and Wound Cleansing/Debridement Products
In 2004, the U.S. market for wound dressings and wound cleansing/debridement products was valued at approximately $778 m ...[more]
- Trends and Opportunities in U.S. Orthopedic Markets for Implant, Reconstruction, and Trauma Products
According to the American Academy of Orthopedic Surgeons, approximately 28.6 million people in the United States sustai ...[more]
- European Markets for Orthopedic Implants and Trauma Products
The European orthopedic implants and trauma products market consists of reconstruction and replacement products for the ...[more]
- Emerging U.S. Markets for Myocardial Revascularization, Repair, and Regeneration Products and Technologies
In the United States (U.S.), cardiovascular disease afflicts more than a quarter of the population, causes more than 5 m ...[more]
- U.S. Markets for Sports Medicine Devices and Products
Each year, approximately 30 million children participate in organized sports and 150 million adults participate in non-w ...[more]
- U.S. Markets for Infection Control and Biosafety Products
Infectious diseases are the leading cause of death worldwide and the third-leading cause of death in the United States. ...[more]
- Current and Emerging Wound Closure Products and Techniques in Europe and the U.S.
In an effort to address the major barriers to the adoption of minimally invasive techniques in wound closure, manufactur ...[more]
- U.S. Markets for Apheresis, Hemostasis, and Stem Cell Therapy Products
In 2001, the U.S. apheresis, hemostasis, and stem cell therapy products market totaled $580.2 million, a figure that is ...[more]
- U.S. Markets for Current and Emerging Orthopedic Biomaterials Products and Technologies
Orthopedic biomaterials technology is taking the orthopedic industry by storm, helping to speed healing of bone, cartila ...[more]
- U.S. Markets for Current and Emerging Wound Closure Technologies, 2001-2011
One of the major barriers to the adoption of minimally invasive techniques in wound closure has been the difficulty asso ...[more]
|
|
178 EMT Companies Found
Search results:
- EMT Company 1198
Next-generation diagnostic platform for personalized medicine ... [more] - EMT Company 587
A fully integrated, affordable, sample-to-result platform for rapid, accurate PCR-based detection/differentiation of inf ... [more] - EMT Company 399
First viable intracellular genetic protein therapy for the treatment of Chronic Heart Failure (\"CHF\") ... [more] - EMT Company 869
Allogeneic cell therapy derived from the human placenta to mimic the natural environment of bone marrow ... [more] - EMT Company 1206
Effective, reliable use of autologous adult stem cells (ASCs) to enhance fusion in spine and orthopedic surgery ... [more] - EMT Company 722
Rapid, point-of-care diagnostic tests for periodontitis/group A strep/systemic fungal infections, capable of detecting v ... [more] - EMT Company 1194
Fibroblast growth factor (FGF) variants for therapeutic and reagent/cell expansion applications with a commercial focus ... [more] - EMT Company 563
Repair and regeneration technology platforms designed to mend and regrow hard tissue (such as bone) and soft tissue (suc ... [more] - EMT Company 1155
Quantitative and qualitative cardiac assays to assist in the diagnosis of cardiovascular diseases at the point of care ... [more] - EMT Company 1114
Endoluminal treatment for morbid obesity ... [more] - EMT Company 560
Rapid DNA-based point-of-care diagnostics ... [more] - EMT Company 214
Gene-based products for the diagnosis and treatment of spinal disorders ... [more] - EMT Company 1179
Tissue-engineered, autologous heart valves for the replacement of malformed or malfunctioning heart valves ... [more] - EMT Company 672
Anti-infective compounds designed to mimic host defense proteins, but with completely synthetic/non-peptide backbones ... [more] - EMT Company 1082
In-situ formed hydrogels for radiation oncology and oncologic surgery ... [more] - EMT Company 1092
Handheld CD4 cell counter ... [more] - EMT Company 1088
Human fibrinogen-based tissue sealant ... [more] - EMT Company 189
Endoscopically-placed devices to prevent GERD, obesity, and irritable bowel syndrome (IBS) ... [more] - EMT Company 975
Polymer technologies for drug delivery and regenerative medicine with applications in orthopedics and spine ... [more] - EMT Company 974
A-FX(TM) is a minimally invasive platform technology for creating an orthopedic implant in-situ which provides superior ... [more] - EMT Company 1025
Low-cost technology to survey the genome in its native state, in context, and at ultra-high resolution, without the need ... [more] - EMT Company 1026
Pressure cycling technology (PCT) to safely, conveniently, and reproducibly control the actions of molecules in biologic ... [more] - EMT Company 1027
1-System for use in spinal surgical procedures such as vertebroplasty, 2-System to provide immediate vascular access thr ... [more] - EMT Company 1013
microRNA-based tests to diagnose various cancers and gastrointestinal diseases ... [more] - EMT Company 1010
Hydrogel materials that can be fabricated into devices, nanogels, and polymer solutions with applications in ophthalmolo ... [more] - EMT Company 1006
"Minimally invasive" gene repair ... [more] - EMT Company 1002
Point-of-care handheld immunoassay system providing high-performance quantitative laboratory blood test results in an in ... [more] - EMT Company 998
Cancer prognostic tests for predicting specific individual patient clinical outcomes ... [more] - EMT Company 997
Genomics-based in vitro diagnostic (IVD) tests developed from FFPE tissue for personalized medicine ... [more] - EMT Company 1044
Stand-alone/rapid/autologous cell harvesting processing and delivery technology ... [more] - EMT Company 8
Cell-based therapy products for the treatment of heart failure secondary to myocardial infarction ... [more] - EMT Company 1050
Diagnostic products for rapid infection determination at the point-of-care (POC) for professional and consumer markets ... [more] - EMT Company 434
Non-molecular bacterial screening, identification, and antibiotic susceptibility testing ... [more] - EMT Company 239
Naturally occurring neuropeptide to treat ischemia associated with myocardial infarction, heart failure, and angina ... [more] - EMT Company 357
Target-specific recombinant human protein focused on spinal fusion surgery ... [more] - EMT Company 941
Non-surgical/injectable tissue revitalization and stabilization to address lower back pain (LBP) and the underlying prob ... [more] - EMT Company 977
Digital fluorescence scanners for molecular pathology research, biomarker development, and clinical molecular diagnostic ... [more] - EMT Company 987
Portable DNA analyzers for on-demand, non-batched testing, with real-time polymerase chain reaction (PCR) results in 30- ... [more] - EMT Company 318
Biocellulose technology that eliminates the risks/complications/limitations inherent in animal, human, and synthetic bio ... [more] - EMT Company 374
Diagnostic methods using microarray gene expression profiling to determine specific properties of tumors ... [more] - EMT Company 962
Functionalized injectable biopolymers for medical applications ... [more] - EMT Company 963
Therapeutic substances for bone regeneration ... [more] - EMT Company 142
1-Bio-therapeutic designed from autologous stem cells and committed to a cardiac lineage before implantation, 2-Correspo ... [more] - EMT Company 966
Vacuum-based clean surface nanotechnology for faster and larger osseointegration ... [more] - EMT Company 820
Biomarkers for the screening and diagnosis of cervical and other cancers ... [more] - EMT Company 806
Technology used in: 1-Finished products designed for micro-surgical/microscopy procedures and robotics and 2-Biosensors ... [more] - EMT Company 817
Non-invasive molecular diagnostics for autism, chronic obstructive pulmonary disease (COPD), multiple sclerosis, and dis ... [more] - EMT Company 912
Microarray-based technology enabling targeted next-generation sequencing of genomic regions of interest ... [more] - EMT Company 914
"Smart" cells than can determine the type of disease/injury present in the body and repair/regenerate tissue accordingly ... [more] - EMT Company 918
Molecular diagnostic technologies for organ transplantation and various complex genetic disorders ... [more] - EMT Company 919
Biomarker discovery platform for detecting Type 2 Diabetes, Prostate Cancer, and Amyotrophic Lateral Sclerosis (ALS, aka ... [more] - EMT Company 920
Targeted molecular assays for onco-diagnostics/personalized medicine ... [more] - EMT Company 924
Minimally invasive radiofrequency (RF) device to treat aging skin ... [more] - EMT Company 874
Tests for the diagnosis/prognosis of cardiovascular disease ... [more] - EMT Company 878
Cancer diagnostic test which enables the development of personalized therapeutics ... [more] - EMT Company 883
Easy-to-use/automated/rapid detection of severe infectious diseases ... [more] - EMT Company 892
Molecular diagnostic/prognostic tests for cancer ... [more] - EMT Company 895
Nanomaterials for angiogenesis/anti-angiogenesis/diagnostic applications ... [more] - EMT Company 898
DNA sequencing technology for the detection of biomarkers for infectious and other diseases ... [more] - EMT Company 900
Non-invasive DNA-based prenatal diagnostic test ... [more] - EMT Company 842
Small shunt-like device implanted into the bloodstream to modify, collect, or eliminate a broad range of Target Cells ... [more] - EMT Company 850
Next-generation implants, stem cell enabling technology, and other minimally invasive surgical instruments ... [more] - EMT Company 854
Polymer implant to repair meniscal tears via tissue regeneration ... [more] - EMT Company 867
Autologous adult stem cell technology, cultured from the nasal passageway, to repair damage resulting from spinal cord i ... [more] - EMT Company 261
Naturally-derived/non-crosslinked/collagen-based extracellular matrix to repair/remodel damaged tissues ... [more] - EMT Company 800
Injectable porous scaffolds/spheres/composites with fully interconnected pores, for multiple applications ... [more] - EMT Company 802
Technologies that integrate bone and cartilage forming peptide and small molecule therapies with osteostimulating matric ... [more] - EMT Company 625
Non-invasive technique for sampling the surface layers of the skin to generate individual genetic profiles for diagnosti ... [more] - EMT Company 805
Resorbable hydrogel that 1-Seals annular tears in the intervertebral disc and 2-Provides an environment for nucleus rege ... [more] - EMT Company 665
3-D scaffold that enhances the biointegration of percutaneous/fully implanted current and next-generation devices ... [more] - EMT Company 814
Electroporation-delivered/DNA-based vaccines against cancers and infectious diseases ... [more] - EMT Company 348
Growth factor and biomaterial addressing the needs of spinal fusion, osteochondral defects, osteoarthritis, dental medic ... [more] - EMT Company 773
Optimization of T cell receptors (TCRs) for use in adoptive T cell therapy - to target and destroy cancerous/infected ce ... [more] - EMT Company 777
Simple, rapid, blood-based cancer tests to provide accurate and individualized clinical information on disease status/tr ... [more] - EMT Company 789
1-Prohealing coronary stent as an alternative to drug-eluting stents (DES), 2-Balloon -expandable/crush-resistant nitino ... [more] - EMT Company 793
Next- generation/predictive blood tests to help warn of potential future health problems ... [more] - EMT Company 741
1-Next-generation, natural fibrin sealant, 2-Human thrombin ... [more] - EMT Company 744
1-Non-embryonic cell technology that creates cells/tissues/organs for virtually anyone needing a transplant, 2-Non-toxic ... [more] - EMT Company 762
Gene expression test for the diagnosis of ambiguous tumors ... [more] - EMT Company 748
In vivo transdifferentiation to regenerate ischemic/diseased organs ... [more] - EMT Company 716
Molecular imaging of apoptosis (programmed cell death) for disease detection/monitoring ... [more] - EMT Company 718
Simple, point-of-care blood test for the detection/monitoring of traumatic brain injury (TBI) ... [more] - EMT Company 721
Therapeutic gene delivery ... [more] - EMT Company 685
Cells derived from bone marrow which can be used in an allogeneic/off-the-shelf setting to treat kidney/other difficult ... [more] - EMT Company 688
Synthetic peptides for tissue regeneration for the treatment of musculoskeletal/vascular/chronic wound diseases ... [more] - EMT Company 698
DNA-based diagnostic tests for early identification/management of cancer/acute diseases ... [more] - EMT Company 709
Nanomaterial-based MRI coil for higher image quality/faster scan times ... [more] - EMT Company 139
Biomimetic coronary stent coating that prevents restenosis/reduces the need for extended courses of dual antiplatelet th ... [more] - EMT Company 664
Injectable gels for localized and controlled release of biologicals ... [more] - EMT Company 89
1-Synthetic alternatives to autograft/cadaver-based bone material, 2-Surgical hemostat as an adherent matrix/impermeable ... [more] - EMT Company 677
Technology for diagnosing breast and ovarian cancers and determining responsiveness to new therapeutics ... [more] - EMT Company 679
1-Image analysis technology for virus detection/analysis, 2-Antiviral drugs ... [more] - EMT Company 645
Recombinant adeno-associated viral (AAV)-based gene therapy as a treatment for congestive heart failure (CHF) ... [more] - EMT Company 651
Surgical implants and biological products for spinal surgery ... [more] - EMT Company 636
Matrix therapy based technology that treats skin ulcers/reduces amputation ... [more] - EMT Company 660
Non-invasive gene expression-based tests for the monitoring of transplant rejection/autoimmune diseases ... [more] - EMT Company 607
MRI contrast agents to monitor the position/quantity of transplanted cells non-invasively in vivo ... [more] - EMT Company 626
Therapeutic gene delivery to treat diabetes/obesity/intestinal disorders/hemophilia/anemia ... [more] - EMT Company 610
Biochips to identify gene expression patterns ... [more] - EMT Company 615
Next-generation personal diagnostics for hematological malignancies/autoimmune disorders ... [more] - EMT Company 621
Cellular therapy to act directly at the level of the cause of autoimmune disorders, the dysregulated immune regulation ... [more] - EMT Company 1180
Compound that can regenerate new blood vessels and has a biodegradable stent ... [more] - EMT Company 550
Next-generation cell-based/tissue-engineered products ... [more] - EMT Company 565
Third-generation cancer-associated biomarkers using proteomics ... [more] - EMT Company 566
Technology for real-time identification/localization of cancer cell clusters to enable complete/residual-free therapeuti ... [more] - EMT Company 551
Extracellular matrix derived from fibroblasts isolated from newborns (NO embryonic stem cells/animal products) ... [more] - EMT Company 589
Therapeutic approaches to prevent the abnormal tissue growth that inhibits recovery from surgical procedures/impairs nor ... [more] - EMT Company 575
Non-invasive/urine-based diagnostic assays for specific cancer types ... [more] - EMT Company 576
Natural cell-based technologies to restore normal neuron function in the central nervous system ... [more] - EMT Company 555
De-cellularized biological scaffolds meant to function like native tissue ... [more] - EMT Company 540
Gene therapy products for the treatment of inherited/acquired diseases. ... [more] - EMT Company 519
Plaque vulnerability biomarkers to detect patients at risk for the development of stroke, myocardial infarction or claud ... [more] - EMT Company 523
Non-epigenetic cell reprogramming technology that enables the generation of patient-identical replacement tissue/organs ... [more] - EMT Company 544
System to process/concentrate cellular components from autologous bone marrow, including adult stem cells, at the point- ... [more] - EMT Company 545
Membrane optimization, coatings technologies, and development of polymers for biomedical applications ... [more] - EMT Company 538
Neo-organs/tissues derived from the patient's own (autologous) cells ... [more] - EMT Company 483
Treatment for ischemia via stem cell-based therapies ... [more] - EMT Company 503
Hydrogel matrix with applications across multiple specialties ... [more] - EMT Company 405
Neowater®, a water-based nanotechnology which has physical properties that mimic intracellular water ... [more] - EMT Company 450
Biomarker assays for the early detection of cancer ... [more] - EMT Company 479
Cellular imaging technology, using the Internet to transfer real-time/secure/accurate cellular resolution images ... [more] - EMT Company 461
Single molecule DNA analysis system, with no requirement for prior sequence information/PCR/cloning/probes ... [more] - EMT Company 448
Detection products for viral/bacterial infections, genetic diseases, mutations, cancers, etc. ... [more] - EMT Company 482
Cellular therapy device to treat liver disease ... [more] - EMT Company 243
Synthetic bone that duplicates the microstructure, composition, and performance of human bone ... [more] - EMT Company 422
Contrast agents/molecular imaging for detection using a modified porous Silicon (mpSi™) platform ... [more] - EMT Company 429
BQT®, a non-invasive point-of-care diagnostic test for osteoporosis and bone fracture risk ... [more] - EMT Company 377
Advanced gene expression and DNA quantification products and services ... [more] - EMT Company 426
Easy-to-use, instrument-free, disposable molecular diagnostic tests ... [more] - EMT Company 430
Optical cell sorters used in stem cell/cell therapy treatments for cancer, autoimmune disease, and regenerative medicine ... [more] - EMT Company 412
RNA-based therapeutics ... [more] - EMT Company 404
Metabolomic profiling of biomarkers for the diagnosis of early forms of dementia and neurodegenerative diseases ... [more] - EMT Company 176
Nanotechnologies for use in orthopedic implants, dental implants, and stents ... [more] - EMT Company 440
Hand-held device to monitor post-operative/trauma patients for early warning signs of sepsis or infection in the bloodst ... [more] - EMT Company 441
Patient-centric data system and analysis tools for translational medicine and research ... [more] - EMT Company 309
Tools for enabling adult stem cell based regenerative medicine ... [more] - EMT Company 369
Methods for treating human tissue based on volumetric bipolar radio frequency ablation (RFA), and surface ablation of ti ... [more] - EMT Company 370
Cell-based epicardial patch designed to promote blood vessel growth in ischemic cardiac tissue ... [more] - EMT Company 1181
Technology that can regenerate nerves ... [more] - EMT Company 12
P-15: a small peptide attachment factor for bone formation in orthopedics ... [more] - EMT Company 292
An internal adhesive biotechnology designed for strength, biocompatibility, and ease-of-use with applications in cardiov ... [more] - EMT Company 295
1-Cartilage implant for the knee, 2-Injectable cell therapy for the spinal disc/nucleus, 3-Bone graft extender to treat ... [more] - EMT Company 308
Lectin-based cell adhesion technology which enables stents that traffic cells in the bloodstream ... [more] - EMT Company 236
Medical devices, utilizing robust tyrosine-based resorbable polymer systems/pharmaceuticals in surgical barriers/cardiac ... [more] - EMT Company 312
High Intensity Focused Ultrasound for incisionless male surgical sterilization ... [more] - EMT Company 264
A protein therapeutic biotreatment that regresses solid tumors and protects against relapses ... [more] - EMT Company 268
Porcine-derived tissue devices for ligament, cartilage, bone, and soft tissue replacement and augmentation ... [more] - EMT Company 270
Next-generation estrogen-based drug-eluting coronary stent and an orthopedics/sports injury pain management device ... [more] - EMT Company 232
A "preventative" vaccine for HIV-AIDs ... [more] - EMT Company 275
PowerCosmetics micro-electronic patches, delivering skincare results faster and more effectively ... [more] - EMT Company 241
PuraMatrix injectable synthetic nanofibrous hydrogels for bone, cartilage and soft tissue regeneration, and drug deliver ... [more] - EMT Company 244
Drug product for the treatment of acute spinal cord injury, cancer, macular degeneration, and glaucoma ... [more] - EMT Company 81
BioDisc, a nucleus replacement product based on an injectable, flexible, and durable protein hydrogel technology ... [more] - EMT Company 245
Nitric oxide-based therapies to accelerate healing of tendon, bone, and other musculoskeletal tissue ... [more] - EMT Company 249
A biological and mechanical solution to annular repair and spine fusion ... [more] - EMT Company 229
Biomaterial that regulates resorbability and enhances bone regeneration ... [more] - EMT Company 234
- EMT Company 188
Cellular implants for orthopedic, trauma, and spinal applications based on a biological form stable matrix ... [more] - EMT Company 191
Bioabsorbable, bioactive, and drug-releasing medical device products for various fields of surgery ... [more] - EMT Company 199
Technology for the manipulation of adult stem cells to repopulate chronically diseased liver tissue ... [more] - EMT Company 201
Endotracheal tube with video, self-locking orthopedic implants, structured TPN lipids, cell therapy for cancer, etc. ... [more] - EMT Company 209
- EMT Company 210
Next-generation bio-medical adhesive, used as a filler for aneurysms in various areas of the body ... [more] - EMT Company 49
Site-specific biological and drug delivery ... [more] - EMT Company 102
Microplate-based electronic biosensor system for label-free, real-time cell based assays ... [more] - EMT Company 130
Nitric oxide releasing surface treatments for enhanced biocompatibility in medical devices ... [more] - EMT Company 133
Unique microsphere-based technology for chronic/acute wounds ... [more] - EMT Company 87
Bioactive synthetic bone graft substitute that is osteostimulative, osteoconductive, antimicrobial, and hemostatic ... [more] - EMT Company 32
Bioresorbable polymer implants for use in a variety of orthopedics and spine surgical applications ... [more] - EMT Company 46
Non-incisional female sterilization ... [more] - EMT Company 23
Molecular diagnostics based on patented, standardized, next-generation, multi-gene expression (StaRT-PCR) products and h ... [more] - EMT Company 73
Implantable encapsulated-cell technology for delivery of biological therapeutics to the nervous system ... [more] - EMT Company 76
Magneto-Optical Enantiomeric Detection (MOPED) for real-time, non-contact analysis of chiral pharmaceuticals ... [more] - EMT Company 7
A five-carbon carbohydrate that increases cellular energy, improving cardiovascular health and tissue function ... [more] - EMT Company 17
Next-generation biomaterials using bioactive-ceramics technology platform ... [more] - EMT Company 27
Prevention of scarring caused by disease, medical intervention, or trauma via a beta emitting biopolymer ... [more] - EMT Company 31
Liposomal formulation of recombinant IL-2 for use as chemotherapy or cancer vaccine adjuvant ... [more] - EMT Company 34
BioSilicon, nano-structured porous silicon for applications in drug delivery, diagnostics, tissue engineering, and ortho ... [more]
|
Member Login
Show only Reports